Zhengye Biotechnology Holding Ltd

Zhengye Biotechnology Holding Ltd (NASDAQ:ZYBT) is a publicly traded company in the Life Sciences sector. Wiseek monitors ZYBT SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

• Zhengye Biotechnology Receives Nasdaq Delisting Warning for Sub-$1.00 Stock Price (2026-06-04)
• Zhengye Biotechnology Reports 21-Cent Loss Per Share for 2025 (2026-04-28)
• Zhengye Biotechnology Reports Substantial FY2025 Net Loss, Revenue Decline, and Material Weakness in Internal Controls; Adopts Dual-Class Share Structure (2026-04-28)
• Shareholders Approve Reverse Stock Split and Reclassification (2026-03-24)
• Zhengye Biotechnology Proposes 20-for-1 Reverse Split and Dual-Class Share Structure to Address Nasdaq Compliance and Consolidate Voting Power (2026-02-28)

Insider Transactions

ZYBT files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.